
In this episode, hosts explore promising results of orforglipron, a new oral GLP-1 receptor agonist, showing significant A1C reduction and weight loss potential.

In this episode, hosts explore promising results of orforglipron, a new oral GLP-1 receptor agonist, showing significant A1C reduction and weight loss potential.

These data highlight the risk level among certain patients with psoriasis of excessive sun exposure, associated commonly with tanning.

1 in 5 patients were incompletely screened for CFLD based on 2023 guidelines, with Hispanic ethnicity and public insurance linked to an increased risk.

The program can indicate the severity of nail psoriasis and allow practitioners to quickly and accurately diagnose patients.

In new preference research, the average participant with AA was willing to trade approximately 5 years of life to avoid impacts associated with 50–100% scalp hair loss.

In these findings, the FamilyPso tool was validated for assessing psoriasis burdens on family members in multiple countries.


Healthier hair and scalp according to Hair & Scalp CARE questionnaire responses was linked to lower levels of perceived stress and good sleep health.

An observational study has indicated a correlation between biologic medications and a lower risk of CVD: more research is needed to determine causality.

The findings may facilitate accurate diagnoses, which could help patients slow or stop permanent hair loss.

In this interview, Chovatiya and Shahriari highlight notable elements of the upcoming Revolutionizing Atopic Dermatitis (RAD) Conference.

Findings suggest BMI and education levels could be clinically relevant modifiable mediators of psoriasis risk attributable to reproductive factors.

A secondary analysis of the data collected by the DASH-Sodium trial indicates that dieting and sodium intake limits are additive in their effects on ASCVD risk.

This month’s Lungcast features a discussion on lung cancer screening guidelines and pulmonary nodule management.

Xanomeline and trospium chloride failed to show significant benefit as an adjunctive schizophrenia treatment to typical antipsychotics but showed promise in select subgroups.

This study highlights the different sex-related disparities as well as those among older adults with atopic dermatitis.

Study findings highlight regional variability in the prevalence of PBC in the US in 2021, additionally suggesting potential barriers to specialist care.

Orchestra BioMed’s Breakthrough Device designation could apply to nearly 8 million patients with uncontrolled hypertension and increased cardiovascular risk

The model could allow cardiologists to inform and prepare patients before symptoms of hypertrophic cardiomyopathy make themselves known.

Participants in the cytisinicline group also had a significantly greater reduction in smoking urges.

Christie M. Ballantyne, MD, discusses the role of plozasiran in managing elevated triglycerides and reducing pancreatitis risk.

This SOCS News Update was filmed on-site at the 2025 AAD meeting, highlighting Nambudiri’s work and the launch of the AAD Clinical Image Collection.


May describes differences between colorectal cancer screening tests and which might be right for patients based on their preferences and values.

The scalability and portability of these ECGs could also allow for a community-based approach to heart healthcare.

Overall, Asthma Control Test (ACT) measures improved by 37%.

Anita Radhakrishnan, MD, leads a community screening effort to detect early heart disease in underserved populations in Pittsburgh.

Tryptase, although identified as the most reliable anaphylaxis biomarker in a recent systematic review, only had a 49% sensitivity.

May discusses currently available NITs for colorectal cancer screening, the continued importance of colonoscopy, and the emergence of blood-based tests.

Analysis suggests that OCT is more consistently accurate and sensitive than color imaging and fluorescein angiography, the accepted standards for imaging.